IDXX IDEXX Lab Total Debt to Capital

IDEXX Laboratories, Inc. (IDXX) proprietary manufacturing plants ensure supply stability, which partially offsets the risks of declining consumer demand. The company's debt-to-equity ratio illustrates the dynamics of its financial recovery, while 0.73 determines the latest valuation metric. Monopoly ownership of analyzers in clinics guarantees a steady cash flow through the mandatory purchase of proprietary consumables.

idexx.com (IDXX): All Debt to Shareholders' Equity Ratio from 07/04/2022 to 10/31/2026

Analytical breakdowns for IDEXX Laboratories, Inc.

- share price and consensus valuation forecast:

Stock Price IDEXX|IDXX - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization IDEXX|IDXX - Full Takeover Company Value

- book capitalization indicators:

Net Assets per Single Share IDEXX|IDXX - Accounting Value of Company|Market Capitalization to Book Value Ratio idexx.com|IDXX - Company Total Asset Base

- debt level and financial liquidity data:

- net income and valuation ratios data:

IDXX - Net Profit

Basic company analysis:IDXX, IDEXX

A conservative investor views this ratio as a measure of financial stability. The ownership of proprietary plants and laboratories by IDEXX Laboratories, Inc. (IDXX) requires a balance between capital expenditures and borrowed funds. Analyzing the current total debt leverage, we compare total liabilities against the net asset value. A low value confirms solvency, while moderate debt optimizes profitability. A stable trend guarantees the long-term operational security of the business.

Key competitors